2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1077
INDUSTRY
405
NIH
102
NETWORK
47
OTHER_GOV
31
FED
4
UNKNOWN
2
INDIV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
8
Barrett Esophagus
5
Myasthenia Gravis
4
Breast Neoplasms
4
Leiomyoma
3
Carcinoma, Hepatocellular
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Lipoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma in Situ
2
Warts
1
Vaginosis, Bacterial
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Syphilis
1
Sexually Transmitted Diseases
1
Retroperitoneal liposarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pilonidal Sinus
1
Papillomavirus Infections
1
Overweight
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
sargramostim
1
pembrolizumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDIV
×
Urinary Bladder Neoplasms
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled